SK plots next phase of growth with plans for $261M 'vaccine ecosystem' in Korea

หน้าแรก / News / SK plots next phase of growth with plans for $261M 'vaccine ecosystem' in Korea


https://www.fiercepharma.com/manufacturing/sk-plots-261m-vaccine-ecosystem-korea



            
                
                                            Recent NewsNew RSV treatment for infants could impact this year’s flu and virus season in Virginia
Recommended Flu Vaccines for Older Adults
Australia’s flu season is hitting kids the hardest. What does this mean for Canada?
สธ.ประชุมแผนไข้เลือดออก หลังอาการไม่เหมือนที่เคยพบ การระบาดพุ่ง 3 เท่า
What to Know About Guillain-Barré Syndrome After Peru Outbreak
			
	
		
	



	
		เกี่ยวกับเรา
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	อ่านเพิ่มเติม


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    Recommended Flu Vaccines for Older Adults                                
                            
                        
                                        
                        
                            
                                
                                    Australia’s flu season is hitting kids the hardest. What does this mean for Canada?                                
                            
                        
                                        
                        
                            
                                
                                    สธ.ประชุมแผนไข้เลือดออก หลังอาการไม่เหมือนที่เคยพบ การระบาดพุ่ง 3 เท่า                                
                            
                        
                                        
                        
                            
                                
                                    What to Know About Guillain-Barré Syndrome After Peru Outbreak                                
                            
                        
                                        
                        
                            
                                
                                    Thanks to viral megatests, a ‘cold’ may not be so common anymore

Related Posts

SK plots next phase of growth with plans for $261M 'vaccine ecosystem' in Korea

Related Health Education